Envoy Medical, Inc. (NASDAQ:COCH) Sees Large Increase in Short Interest

Envoy Medical, Inc. (NASDAQ:COCH) saw a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 44,400 shares, an increase of 300.0% from the February 29th total of 11,100 shares. Approximately 0.7% of the shares of the company are sold short. Based on an average daily volume of 400,100 shares, the days-to-cover ratio is presently 0.1 days.

Wall Street Analyst Weigh In

Separately, Northland Securities began coverage on shares of Envoy Medical in a report on Thursday, December 21st. They issued an “outperform” rating on the stock.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Envoy Medical stock. Weiss Asset Management LP bought a new position in shares of Envoy Medical, Inc. (NASDAQ:COCH) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 20,000 shares of the company’s stock, valued at approximately $37,000. Weiss Asset Management LP owned approximately 0.10% of Envoy Medical as of its most recent SEC filing. Institutional investors and hedge funds own 8.59% of the company’s stock.

Envoy Medical Trading Down 3.5 %

Envoy Medical stock opened at $3.91 on Thursday. Envoy Medical has a twelve month low of $0.75 and a twelve month high of $11.72. The firm has a 50-day moving average of $3.17.

About Envoy Medical

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices, such as auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.